Addus HomeCare (NASDAQ:ADUS) Shares Gap Down to $119.52

Addus HomeCare Co. (NASDAQ:ADUS) gapped down prior to trading on Thursday . The stock had previously closed at $119.52, but opened at $112.49. Addus HomeCare shares last traded at $112.18, with a volume of 144,447 shares trading hands.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several analyst reports. TD Cowen increased their price objective on Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Stephens increased their price objective on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. Oppenheimer raised their price target on Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. Bank of America raised their price target on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. One research analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus price target of $113.43.

Addus HomeCare Stock Performance

The firm has a fifty day simple moving average of $108.99 and a 200-day simple moving average of $99.65. The company has a market cap of $1.85 billion, a PE ratio of 27.84, a price-to-earnings-growth ratio of 2.30 and a beta of 1.02. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.84 earnings per share. On average, research analysts forecast that Addus HomeCare Co. will post 4.36 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently added to or reduced their stakes in the company. Principal Securities Inc. acquired a new stake in Addus HomeCare in the fourth quarter valued at about $26,000. GAMMA Investing LLC acquired a new stake in Addus HomeCare in the fourth quarter valued at about $34,000. EntryPoint Capital LLC acquired a new stake in Addus HomeCare in the first quarter valued at about $44,000. Assetmark Inc. lifted its position in Addus HomeCare by 33.3% in the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after purchasing an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. acquired a new stake in Addus HomeCare in the fourth quarter valued at about $214,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.